BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 24467820)

  • 1. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.
    West AH; Godley LA; Churpek JE
    Ann N Y Acad Sci; 2014 Mar; 1310(1):111-8. PubMed ID: 24467820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].
    Király PA; Kállay K; Marosvári D; Benyó G; Szőke A; Csomor J; Bödör C
    Orv Hetil; 2016 Feb; 157(8):283-9. PubMed ID: 26876264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
    Tawana K; Drazer MW; Churpek JE
    Leukemia; 2018 Jul; 32(7):1482-1492. PubMed ID: 29483711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial myelodysplastic syndrome/acute myeloid leukemia.
    Churpek JE
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia.
    Holme H; Hossain U; Kirwan M; Walne A; Vulliamy T; Dokal I
    Br J Haematol; 2012 Jul; 158(2):242-248. PubMed ID: 22533337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
    Király AP; Kállay K; Gángó A; Kellner Á; Egyed M; Szőke A; Kiss R; Vályi-Nagy I; Csomor J; Matolcsy A; Bödör C
    Pathol Oncol Res; 2018 Jan; 24(1):83-88. PubMed ID: 28357685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial myelodysplasia and acute myeloid leukaemia--a review.
    Owen C; Barnett M; Fitzgibbon J
    Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited predisposition to acute myeloid leukemia.
    Godley LA
    Semin Hematol; 2014 Oct; 51(4):306-21. PubMed ID: 25311743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Predispositions to Myelodysplastic Syndrome.
    Bannon SA; DiNardo CD
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27248996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
    Churpek JE; Pyrtel K; Kanchi KL; Shao J; Koboldt D; Miller CA; Shen D; Fulton R; O'Laughlin M; Fronick C; Pusic I; Uy GL; Braunstein EM; Levis M; Ross J; Elliott K; Heath S; Jiang A; Westervelt P; DiPersio JF; Link DC; Walter MJ; Welch J; Wilson R; Ley TJ; Godley LA; Graubert TA
    Blood; 2015 Nov; 126(22):2484-90. PubMed ID: 26492932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
    Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
    Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
    Wang K; Zhou F; Cai X; Chao H; Zhang R; Chen S
    Hematology; 2020 Dec; 25(1):211-218. PubMed ID: 32476595
    [No Abstract]   [Full Text] [Related]  

  • 16. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
    Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
    Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognizing familial myeloid leukemia in adults.
    Nickels EM; Soodalter J; Churpek JE; Godley LA
    Ther Adv Hematol; 2013 Aug; 4(4):254-69. PubMed ID: 23926458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
    Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
    Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial myelodysplastic syndromes: a review of the literature.
    Liew E; Owen C
    Haematologica; 2011 Oct; 96(10):1536-42. PubMed ID: 21606161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
    Duncavage EJ; Tandon B
    Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.